Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US.

ABSTRACT:

Objective

There is increasing evidence supporting the clinical utility of next generation sequencing for identifying fetal genetic disorders. However, there are limited data on the demand for and accessibility of these tests, as well as payer coverage in the prenatal context. We sought to identify clinician perspectives on the utility of prenatal exome sequencing (ES) and on equitable access to genomic technologies for the care of pregnancies complicated by fetal structural anomalies.

Method

We conducted two focus group discussions and six interviews with a total of 13 clinicians (11 genetic counselors; 2 Maternal Fetal Medicine/Geneticists) from U.S. academic centers and community clinics.

Results

Participants strongly supported ES for prenatal diagnostic testing in

SUBMITTER: Sahin-Hodoglugil NN 

PROVIDER: S-EPMC10846391 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature